Summary Murine L5178Y-ML cells, when transplanted subcutaneously into the flank of (BALB/c x DBA/ 2)F, mice, grew locally and always formed spontaneous metastases in the liver. Even after surgical removal of the primary tumour mass 5 or 7 days after tumour cell inoculation, all mice died due to liver metastases within 18 days. Using this model of tumour metastasis, we examined whether serine protease or deoxyribonuclease I (DNase I) would affect metastasis. Spontaneous liver metastasis of L5 1 78Y-ML cells was (Sugihara et al., 1990) . We also observed that these alterations in frequency of metastasis were direct reflections of changes of sequestration intensity in the lungs of the tumour cells, probably due to aggregation and disaggregation in vivo (Sugihara et al., submitted for publication). Our electron microscopic study showed that this aggregation seemed to be caused by formation of a sleeve-like structure which surrounded the cells and connected them with each other. This structure probably originated from the cell surface glycocalyx in some sort of association with DNA molecules (Sugihara et al., 1991 Recently we examined a spontaneous metastasis model in mice using the L5178Y-ML cell line established by Watanabe and his co-workers (Watanabe et al., 1988) . The L5178Y-ML cell line was derived from L5178Y, a murine T-lymphoma cell line isolated from a methylcholanthrene-induced lymphoma in DBA/2 mice. In order to establish a liver-oriented metastatic tumour cell line, cells were propagated further sequential cycles of subcutaneous inoculation of L5178Y cells which were isolated from the metastatic liver masses. L5178Y-ML cells, therefore, metastasised predominantly to the liver after intravenous or subcutaneous injection (Watanabe et al., 1988) . In our preliminary study. L5178Y-ML cells were also sensitive to serine proteases and to DNase I in tumour cell aggregation and disaggregation, respectively. The present study was, therefore, undertaken to confirm the effects of protease and nuclease in altering the blood-borne metastatic rate in this model which more closely resembles clinical blood-borne metastasis.
The process of metastasis is complicated, involving release of cells from a primary tumour, dissemination to distant sites, arrest in the microcirculation in other organs, and infiltration into these organs and growth in secondary sites (Fidler et al., 1978; Roos & Dingemans, 1979; Poste & Fidler, 1980) . Fidler (1973) originally demonstrated the importance of cluster formation of circulating tumour cells in metastasis using B16 melanoma cells in mice. It has also been shown that an important event in blood-borne metastasis is intercellular adhesion and aggregation of circulating tumour cells (Nicolson & Winkelhake, 1975) .
We have found that serine proteases such as achymotrypsin or elastase caused tumour cell aggregation in vitro and enhanced blood-borne lung metastasis in vivo in the rat ascites tumour cell lines, AH-130, Deoxyribonuclease I (DNase I) dispersed the tumour cell aggregates and reduced the lung metastasis (Sugihara et al., 1990) . We also observed that these alterations in frequency of metastasis were direct reflections of changes of sequestration intensity in the lungs of the tumour cells, probably due to aggregation and disaggregation in vivo (Sugihara et al., submitted for publication). Our electron microscopic study showed that this aggregation seemed to be caused by formation of a sleeve-like structure which surrounded the cells and connected them with each other. This structure probably originated from the cell surface glycocalyx in some sort of association with DNA molecules (Sugihara et al., 1991 Recently we examined a spontaneous metastasis model in mice using the L5178Y-ML cell line established by Watanabe and his co-workers (Watanabe et al., 1988) . The L5178Y-ML cell line was derived from L5178Y, a murine T-lymphoma cell line isolated from a methylcholanthrene-induced lymphoma in DBA/2 mice. In order to establish a liver-oriented metastatic tumour cell line, cells were propagated further sequential cycles of subcutaneous inoculation of L5178Y cells which were isolated from the metastatic liver masses. L5178Y-ML cells, therefore, metastasised predominantly to the liver after intravenous or subcutaneous injection (Watanabe et al., 1988 
Surgical removal of subcutaneous tumours
In studies on effects of the enzyme treatments on mortality, L5178Y-ML cells (1 x 106 per mouse) were subcutaneously inoculated in the usual manner. On day 7, however, the primary tumour mass was excised surgically under ether anaesthesia, and the wound was closed with silk threads. The size of the removed mass was measured. Alpha-chymotrypsin (1.0 mg/mouse/day) or DNase I (0.1 U/mouse/day) was intravenously injected for 3 days either before or after primary tumour removal, and the survival periods were compared. Autopsies were performed in all mice.
Histological examination For light microscopic examination, small pieces of tissues were fixed with 10% formalin and embedded in paraffin in usual ways. The tissue specimens sliced were stained with hematoxylin and eosin.
For scanning electron microscopy, the liver was fixed with a perfusion method. Under pentobarbital anaesthesia, 0.1 M PBS containing heparin (1 IU g-' animal weight) was intravenously injected into the tail vein and the thoracoabdominal cavity was surgically opened. The left ventricle was cannulated for systemic perfusion with 3% glutaraldehyde in 0.1 MPBS at room temperature, and the right atrium was cut for drainage. The perfused liver was removed and cut into pieces approximately 2 mm in thickness, and fixed in 1% osmium tetroxide in 0.1 MPBS. After dehydration using graded series of ethanol, the fixed tissues were subjected to frozen liquid cracking (Hamano et al., 1973) . The tissues were then dried using the t-butyl alcohol freeze-drying method (Inoue & Osatake, 1988) , and the cracked surface was coated by platinum-paladium and viewed in a scanning electron microscope (JSM-6400FK) with an accelerating voltage of 20kV.
Statistical analysis Differences in liver weight were compared by the computerised, non-parametric, Mann-Whitney U-test. Survival comparisons between groups were tested for significance by the Kaplan-Meier method.
Results
Spontaneous metastasis of L5178Y-ML cells to the liver In all mice implanted with L5178Y-ML cells, a tumour mass developed which became macroscopically recognisable at day 5. After 12 days, the animals were killed under ether anaethesia and visceral organs including the liver, lungs, kidneys and spleen were examined macroscopically and histologically. In all cases, severe metastasis in the liver but in no other organs was observed. As shown in Table I , the mean weight of the liver in the tumour-bearing mice was 2.27 ± 0.14 g, which was 2.7 fold heavier than that in the normal mice (0.85 ± 0.08 g). The mean size of the primary tumour mass at day 12 was 5,229 ± 441 mm3. Since with a-chymotrypsin (1.0 mg/injection), DNase I (0.1 U/ injection) or PBS, and the remaining three groups were treated similarly from day 5 to day 7. All animals were sacrificed on day 14 and the liver weight and the subcutaneous tumour size were measured.
There was, however, no difference between the groups treated at different times (Table II) . There were, however, significant statistical differences between the different treatment. Alpha-chymotrypsin treatment increased liver weight from 2.26 to 2.92 g, whereas DNase I treatment reduced it to 1.55 g. In contrast, neither x-chymotrypsin nor DNase I affected tumour growth at the original site. The results indicated that both a-chymotrypsin and DNase I affected the intensity of liver metastasis.
Histological observation on liver metastases Light microscopy revealed a wide variation in the size of the foci of tumour metastasis in the enlarged liver in the group treated with PBS ( Figure la) . The x-chymotrypsin-treated group (Figure lb) showed diffuse infiltration of L5178Y-ML cells and severe centrilobular necrosis, a few liver cells remaining among the metastatic foci. In contrast, in the DNase I-treated group (Figure lc, ld) , the numbers of metastatic foci were fewer and their sizes smaller. The To elucidate the mechanism of DNase I in preventing liver metastasis, we attempted to observe arrest of tumour cells in the microvasculature of the liver 10 days after cutaneous inoculation by scanning electron microscopy with the freezed fracture technique. As shown in Figure 2, Figure 3 , while o-chymotrypsin treatment had no significant effect on survival period, DNase I treatment prolonged the survival period up to 24 days. The same experiment was carried out three times, and similar results were obtained. Although the prolongation was statistically significant, the effect was not satisfactory. We speculated that because of the presence of the primary tumour mass, tumour cells might have a chance to metastasise to the liver after disappearance of the intravenously injected DNase I. Therefore, in the next experiment, we examined the effect of DNase I treatment on the mortality of mice in combination with surgical resection of the primary tumour mass. When the primary tumour mass was resected on day 7, significant prolongation of survival was achieved in the DNase I group treated on days 5, 6 and 7 after tumour cell inoculation compared to the untreated group (P<0.01, Figure 4 ). This experiment was repeated twice with similar results. However, the increase in survival period was less when the DNase I treatment was carried out on days 8, 9 and 10 after tumour cell inoculation. Autopsies revealed marked liver metastases which were the cause of death in every animal.
Discussion
The augmenting and reducing effects of a-chymotrypsin and DNase I on blood-borne metastasis were originally demonstrated in a rat model in which metastatic foci were produced in the lung by injecting the tumour cells intravenously (Sugihara et al., 1990) . However, this experiment is open to criticism in that the introduction of so many tumour cells into the circulation at once seems unlikely under clinical conditions. The present confirmatory results on the effects of these enzymes in the clinically more realistic L5178Y-ML metastatic model are therefore important.
From the clinical sense in regard to tumour therapy, the effect of DNase I on reducing the metastatic rate from the initial cutaneous mass to the liver is more interesting than the effect of oc-chymotrypsin. The inhibitory effect of DNase I on tumour metastasis has also been reported by Salganik et al (1967) who demonstrated reduction of leukaemic cell metastasis in AKR mice by treatment with repetitive intraperitoneal DNase injection.
In the present investigation, DNase I administration into the tail vein at 3 to 5 days or at 5 to 7 days after the subcutaneous tumour inoculation caused potent inhibition of liver metastasis (Table II) . DNase I administration did not affect the growth of the subcutaneous tumours. In addition, the failure of primary tumour resection at 5 days to prevent liver metastasis indicated the presence of tumour cells with metastatic potency in the circulation at least 5 days after subcutaneous tumour cell inoculation. These results indicated Our observations with the scanning electron microscope suggested that the prevention of metastasis might be a consequence of the reduction of tumour cell arrest in the microvasculature in the liver. In association with this reduction of arrest, the number of mesh-or cloth-shape structures, which surrounded the arrested tumour cells, decreased. Destruction of similar structures, which were composed of DNA, has been previously observed in vitro, when tumour cell aggregates were treated with DNase I to cause disaggregation (Sugihara et al., 1991) .
Therefore, the effect of DNase I on reducing metastasis might relate to this disaggregation. In the previous experimental model, DNase I inhibited blood-borne lung metas- tasis, and in this model, it inhibited liver metastasis. The effect of DNA in causing or enhancing blood-borne metastasis does not, therefore, seem to be organ specific. On the other hand, it is known that occurrence of metastases of the L5178Y-ML cells following intravenous or subcutaneous inoculation is almost solely in the liver (Watanabe et al., 1988) . This liver specificity was again demonstrated in the present study. We speculated the liver specific arrest of tumour cells might be mediated basically by specific intercellular adhesion molecules on the tumour cells and on the endothelial cells of liver microvasculature. This type of interaction might, however, be easily prevented by shear stress of the circulation, and might require some predisposing phenomena such as intercellular aggregation of tumour cells or formation of tumour emboli. The effect of DNA might be to cause such aggregation of tumour cells. The source of the DNA is probably chromatin of tumour cells which have been destroyed in the circulation, since it has been reported that most of the tumour cells injected in the circulation were initially arrested in capillary beds, only a few (0.1%) surviving to develop into colonies (Fidler, 1970) . inoculated with L5178Y-ML cells. The primary tumour mass was surgically removed on the 7th day after the tumour cell inoculation. Animals were divided into five groups (n = 5 in each group) and treated as follows; intravenously injected with either PBS (A), 1.0 mg a-chymotrypsin per mouse on days 5, 6 and 7 (0), or on days 8, 9 and 10 (A), or 0.1 U DNase I per mouse on days 5, 6 and 7 (0), or on days 8, 9 and 10 (U).
The most important result of the present study must be the life span-prolongation effect of DNase I in combination with surgical treatment of the primary lesion. Surgical removal of the subcutaneously inoculated tumour alone had no prolonging effect and all mice died from micrometastases in early periods. Many combinations of DNase I treatment with other tumour therapies are possible. Thus, DNase I treatment may be potentially useful in the prevention of cancer metastasis, though further detailed work is required.
